Screening for glaucoma using advanced AI technology
DP24-081 The Glaucoma and Retinopathy Screening Study
['FUNDING_U01'] · MASSACHUSETTS EYE AND EAR INFIRMARY · NIH-11029389
This study is working on a new way to help find glaucoma early, especially for people in underserved communities, by using smart technology to make eye tests easier and more accurate, so we can catch problems before they lead to vision loss.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS EYE AND EAR INFIRMARY (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11029389 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the early detection of glaucoma, a leading cause of blindness, particularly among underserved minority populations. By utilizing advanced autonomous AI technology and virtual perimetry, the study aims to enhance the accuracy and accessibility of glaucoma screening. The approach seeks to identify individuals at risk before significant vision loss occurs, thereby addressing health inequities in diagnosis and treatment. The program is designed to be cost-effective and leverage existing infrastructure used for diabetic eye disease screening.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from underserved minority populations who may be at higher risk for undiagnosed glaucoma.
Not a fit: Patients who are already diagnosed with glaucoma and receiving treatment may not benefit directly from this screening initiative.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of glaucoma, significantly reducing the risk of blindness in high-risk populations.
How similar studies have performed: Previous research has shown success in using AI for screening diabetic eye disease, indicating a promising potential for similar approaches in glaucoma detection.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS EYE AND EAR INFIRMARY — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FRIEDMAN, DAVID S — MASSACHUSETTS EYE AND EAR INFIRMARY
- Study coordinator: FRIEDMAN, DAVID S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.